Intrinsic Value of S&P & Nasdaq Contact Us

Glaukos Corporation GKOS NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$143.44
+19%

Glaukos Corporation (GKOS) — Analyst outlook / Analyst consensus target is. Based on 24 analyst ratings, the consensus is bullish — 18 Buy, 5 Hold, 1 Sell.

The consensus price target is $143.44 (low: $127.00, high: $165.00), representing an upside of 19% from the current price $120.52.

Analysts estimate Earnings Per Share (EPS) of $-1.83 and revenue of $0.38B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.77 vs est $-1.83 (missed -51.3%). 2025: actual $-3.28 vs est $-0.82 (missed -298.8%). Analyst accuracy: 46%.

GKOS Stock — 12-Month Price Forecast

$143.44
▲ +19.02% Upside
Average Price Target
Based on 24 Wall Street analysts offering 12-month price targets for Glaukos Corporation, the average price target is $143.44, with a high forecast of $165.00, and a low forecast of $127.00.
The average price target represents a +19.02% change from the last price of $120.52.
Highest Price Target
$165.00
Average Price Target
$143.44
Lowest Price Target
$127.00

GKOS Analyst Ratings

Buy
24
Ratings
18 Buy
5 Hold
1 Sell
Based on 24 analysts giving stock ratings to Glaukos Corporation in the past 3 months
Rating breakdown
Buy
18 75%
Hold
5 21%
Sell
1 4%
75%
Buy
18 analysts
21%
Hold
5 analysts
4%
Sell
1 analysts

EPS Estimates — GKOS

46%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$2.77 vs Est –$1.83 ▼ 33.9% off
2025 Actual –$3.28 vs Est –$0.82 ▼ 74.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — GKOS

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.383B vs Est $0.379B ▲ 1.2% off
2025 Actual $0.507B vs Est $0.500B ▲ 1.4% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message